ISSN:

Journal Home

Molecular Therapy - Oncolytics Q1 Unclaimed

Cell Press United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Therapy - Oncolytics is a journal indexed in SJR in Molecular Medicine and Oncology with an H index of 42. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2880 €. The scope of the journal is focused on cell biology, oncolytics, molecular therapy, gene therapy, cancer. It has an SJR impact factor of 1,494 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,494.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Molecular Medicine (Q1) Oncology (Q1) Pharmacology (medical) (Q1) Cancer Research (Q2)

Price

2880 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,494

SJR Impact factor

42

H Index

97

Total Docs (Last Year)

488

Total Docs (3 years)

5554

Total Refs

2595

Total Cites (3 years)

478

Citable Docs (3 years)

5.35

Cites/Doc (2 years)

57.26

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cell Stem Cell Q1
Molecular Cancer Q1
Pharmacological Reviews Q1
Genome Medicine Q1
Journal for ImmunoTherapy of Cancer Q1

Compare this journals

Aims and Scope

Cell biology Oncolytics Molecular therapy Gene therapy Cancer